28 Jul 2013

Decision in the case of Faisal Aldossri


ITF Anti-Doping

29 July 2013 – London, ENGLAND

The International Tennis Federation announced today that it recognises and respects the 2-year ban imposed on Faisal Aldossri by the Saudi Arabian Anti-Doping Committee (SAADC) for an Anti-Doping Rule Violation under Article 2.1 of the WADA Code (Presence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s sample).

Mr Aldossri, a 32-year old player from Saudi Arabia provided a sample on 1 May 2013 in connection with his participation at the Saudi Arabian Tennis Championships. That sample was sent to the WADA-accredited laboratory in New Delhi, India for analysis, and was found to contain amphetamine. Amphetamine is a Prohibited Substance under section S6 of the 2013 WADA List of Prohibited Substances and Prohibited Methods. Mr Aldossri was therefore suspended by SAADC for a period of two years, starting on 9 June 2013 and so ending at midnight on 8 June 2015.

As a Signatory to the WADA Code, the ITF (and, therefore, its member National Associations) is obliged to recognise and respect decisions of other Code Signatories that are consistent with the Code and within that Signatory’s authority (Article 15.4).

The Tennis Anti-Doping Programme is a comprehensive and internationally recognised
drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.